newsfilter
← Latest News
Business Wire·

GeneDx Reports Second Quarter 2026 Financial Results

Reported second quarter 2026 revenue of $114.4 million, including $100.3 million in exome and genome revenue Reported exome and genome volume growth of 32% year-over-year Reported adjusted gross margin(1) of 70%